Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
A large retrospective database analysis conducted in 2025 specifically examined whether GLP-1 therapies may be associated with increased short-term risk of a SIBO diagnosis, compared to other diabetes treatments
However, in the 5 years its been on the market, according to the Calocarb website, there have been no reports of other concerning side effects
That said, it's worth knowing the difference between typical irritation and something that needs prompt attention
doi:10.1111/dom.15538 171
Nexafed, a tamper-resistant dosage form of the nasal decongestant pseudoephedrine, has been shown to be pharmacokinetically equivalent to Sudafed brand of the same nasal decongestant
Get the details in our Beetroot Juices, Powders, and Chews Review , which includes our Top Picks
